1 shares
Channel 12 reports that one million vaccines from the US biotech company Moderna will arrive in Israel next week, rather than in March as had previously been agreed.
The report is not immediately confirmed by the Health Ministry.
If confirmed, however, it could make up for a shortfall predicted by the ministry in January, before new batches of the Pfizer-BioNTech shot arrive.
A nurse gives a volunteer an injection during trials for Moderna’s COVID-19 vaccine in Binghamton, New York, July 27, 2020. (AP Photo/Hans Pennink) I m proud to work at The Times of Israel
I’ll tell you the truth: Life here in Israel isn’t always easy. But it s full of beauty and meaning.
Accusing China of vaccine diplomacy simply groundless - China News sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.
2020-12-31 09:57 By: Xinhua The emergency use of vaccine mainly targets groups of people with higher risks of infection. They include medical workers, customs officers, primary-level epidemic prevention workers, overseas returnees and people working in cross-border cold-chain logistics and isolation centers. Experts remind people that they should still take protective measures after receiving the vaccination.
BEIJING, Dec. 30 (Xinhua) With the recent increase of sporadic COVID-19 cases and progress in the development and manufacture of vaccines, China s emergency use of vaccines has expanded to a larger scale.
Inoculation of key groups has already started in Shanghai, Guangdong, Jiangxi, Shandong and the city of Wuhan in central China s Hubei Province.
Xinhua Photos of the Day (Dec 31) bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
Made In China: Yet Another COVID-19 Vaccine Hits The Streets.
A staff member checks the packaging quality of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020. Photo: Xinhua
BEIJING, China–December 30th, 2020–China on Thursday announced that it has granted market approval attached with conditions for its first homemade COVID-19 vaccine, which was developed by Sinopharm, marking a monumental step in the battle against the pandemic that has killed 1.79 million globally.
The inactivated vaccine developed by Beijing Biological Products Institute under Sinopharm’s subsidiary China National Biotec Group (CNBG), got official authorization from China’s National Medical Products Administration on Wednesday, Chen Shifei, deputy head of the National Medical Products Administration, said at Thursday’s press conference.